Abstract
Guanylate kinases (GMPK) from Mycobacterium tuberculosis, Mus musculus and Saccharomyces cereviae were submitted to virtual screening in order to determine protein-ligand interactions specific to M. tuberculosis. The opening of the cleft between CORE, LID and GMP domains was found to have a large influence on the established interactions and on the determination of ligands binding specifically to the M. tuberculosis GMPK. An extended definition of the active site pocket, allowing to be more discriminant between Mycobacterium tuberculosis and M. musculus, is given. A virtual screening run with the extended pocket definition, was used to select compounds having high docking scores on M. tuberculosis GMPK and low ones on M. musculus GMPK. The protein residues involved in hydrogen bonds with ligands were the same than in the GMPK-GMP complex, but the chemical functions of the ligand involved in these hydrogen bonds are often different. On the other hand, the hydrophobic interactions are different from the ones observed in the GMPK-GMP structure, and may be a way to increase the specificity between the M. tuberculosis and M. musculus GMPKs.
Keywords: Mycobacterium tuberculosis, GMPK, Guanylate monophosphate kinase, Virtual screening, ICM
Letters in Drug Design & Discovery
Title: Virtual Screening of the Guanylate Monophosphate Kinase (GMPK) Family: Investigating the Rules of Ligand Specificity
Volume: 5 Issue: 5
Author(s): Therese E. Malliavin, Helene Munier-Lehman and Veronique Stoven
Affiliation:
Keywords: Mycobacterium tuberculosis, GMPK, Guanylate monophosphate kinase, Virtual screening, ICM
Abstract: Guanylate kinases (GMPK) from Mycobacterium tuberculosis, Mus musculus and Saccharomyces cereviae were submitted to virtual screening in order to determine protein-ligand interactions specific to M. tuberculosis. The opening of the cleft between CORE, LID and GMP domains was found to have a large influence on the established interactions and on the determination of ligands binding specifically to the M. tuberculosis GMPK. An extended definition of the active site pocket, allowing to be more discriminant between Mycobacterium tuberculosis and M. musculus, is given. A virtual screening run with the extended pocket definition, was used to select compounds having high docking scores on M. tuberculosis GMPK and low ones on M. musculus GMPK. The protein residues involved in hydrogen bonds with ligands were the same than in the GMPK-GMP complex, but the chemical functions of the ligand involved in these hydrogen bonds are often different. On the other hand, the hydrophobic interactions are different from the ones observed in the GMPK-GMP structure, and may be a way to increase the specificity between the M. tuberculosis and M. musculus GMPKs.
Export Options
About this article
Cite this article as:
Malliavin E. Therese, Munier-Lehman Helene and Stoven Veronique, Virtual Screening of the Guanylate Monophosphate Kinase (GMPK) Family: Investigating the Rules of Ligand Specificity, Letters in Drug Design & Discovery 2008; 5 (5) . https://dx.doi.org/10.2174/157018008784912045
DOI https://dx.doi.org/10.2174/157018008784912045 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
A Comprehensive Review on Recent advances in Synthesis & Pharmacotherapeutic potential of Benzothiazoles
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Thiazolidinedione: A Privileged Scaffold for the Development of Anticancer Agents
Current Topics in Medicinal Chemistry Gene Therapy Using IL-12 Family Members in Infection, Auto-Immunity, and Cancer
Current Gene Therapy Bioengineering RNA Silencing Across the Life Kingdoms
Recent Patents on Biotechnology Cytoplasmic and Nuclear Accumulation of Antisense Oligomers Incubated as Streptavidin Delivery Nanoparticles
Current Radiopharmaceuticals Microwave-assisted Single Step Cinnamic Acid Derivatization and Evaluation for Cytotoxic Potential
Current Pharmaceutical Biotechnology Anti-evolution Drugs: A New Paradigm to Combat Drug Resistance
Letters in Drug Design & Discovery Overview of Coumarins and its Derivatives: Synthesis and Biological Activity
Letters in Organic Chemistry An Integrated Drug Development Approach Applying Topological Descriptors
Current Computer-Aided Drug Design HLA-DR: Molecular Insights and Vaccine Design
Current Pharmaceutical Design Efflux Pump Inhibitors: A Novel Approach to Combat Efflux-Mediated Drug Resistance in Bacteria
Current Drug Targets Fighting Diabetes: Lessons from Xenotransplantation and Nanomedicine
Current Pharmaceutical Design Bacterial β-Ketoacyl-Acyl Carrier Protein Synthase III (FabH) as a Target for Novel Antibacterial Agents Design
Current Medicinal Chemistry Bacterial Resistance: Antibiotics of Last Generation used in Clinical Practice and the Arise of Natural Products as New Therapeutic Alternatives
Current Pharmaceutical Design Immune Therapy of Multiple Sclerosis - Future Strategies
Current Pharmaceutical Design Design, Synthesis and Biological Evaluation of Anti-tuberculosis Agents based on Bedaquiline Structure
Medicinal Chemistry Transcriptional Regulation and Expression of CYP3A4 in Hepatocytes
Current Drug Metabolism Nano Particles: Emerging Warheads Against Bacterial Superbugs
Current Topics in Medicinal Chemistry Synthesis of 99mTc-Rifabutin: A Potential Tuberculosis Radiodiagnostic Agent
Infectious Disorders - Drug Targets Inhibitory MHC Class I Receptors on Myeloid Cells
Current Immunology Reviews (Discontinued)